Elevated testosterone levels – either naturally occurring or from use of testosterone replacement therapy (TRT), does not increase prostate-specific antigen (PSA) levels or prostate cancer risk, according to new research. “Many urologists are concerned that TRT may accelerate prostate growth not only in benign disease but also in cancer,” said Peter Boyle, MD, with the International Prevention Research Institute in Ecully, France. The theory is that most prostate cancers respond to androgen deprivation therapy. Thus, testosterone is thought to stimulate prostate growth and prostate cancer. Boyle set out to identify whether there is a link between testosterone and prostate cancer ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.